title: Delayed-onset heparin-induced thrombocytopenia without thrombosis in a patient receiving postoperative thromboprophylaxis with rivaroxaban.
authors.forename: Brigitte
authors.initials: B
authors.lastname: Tardy-Poncet
authors.forename: Michèle
authors.initials: M
authors.lastname: Piot
authors.forename: Aurélie
authors.initials: A
authors.lastname: Montmartin
authors.forename: Aimé
authors.initials: A
authors.lastname: Burdier
authors.forename: Emilie
authors.initials: E
authors.lastname: Chalayer
authors.affiliation: Bernard Tardy, CHU - Intensive care, InsermCIE3, CHU Saint Etienne, Saint Etienne, Loire 42055, France, Tel.: +33 4 77 12 07 97, Fax: +33 4 77 12 78 20, E-mail: bernardtardy@yahoo.fr.
authors.forename: Bernard
authors.initials: B
authors.lastname: Tardy
mesh_terms: D000368:Aged; D019645:Arthroplasty, Replacement, Knee / Q000009:adverse effects*; D001780:Blood Coagulation Tests; D065427:Factor Xa Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005343:Fibrinolytic Agents / Q000009:adverse effects*; D006470:Hemorrhage / Q000139:chemically induced; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D018579:Patient Selection; D018570:Risk Assessment; D012307:Risk Factors; D000069552:Rivaroxaban / Q000009:adverse effects / Q000627:therapeutic use*; D013921:Thrombocytopenia / Q000097:blood / Q000139:chemically induced* / Q000175:diagnosis; D013997:Time Factors; D016896:Treatment Outcome; D054556:Venous Thromboembolism / Q000209:etiology / Q000517:prevention & control*
chemical_list: D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents; D006493:Heparin; D000069552:Rivaroxaban